CryoSpray Ablation(tm)Thoracic Patient Registry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00785239|
Recruitment Status : Withdrawn (Business Reasons)
First Posted : November 5, 2008
Last Update Posted : June 25, 2015
|Condition or disease|
|Lung Cancer Emphysema Chronic Bronchitis COPD Asthma Sarcoidosis Mesothelioma|
The proposed registry is a prospective, multi-center study of patients that are currently undergoing CryoSpray Ablation™. A maximum of 50 investigational sites will participate in this study.
The study population consists of patients who are being treated with the CryoSpray Ablation™ System for thoracic diseases. Enrolled subjects must have a signed consent form for data collection.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||CryoSpray Ablation(tm)Thoracic Patient Registry|
|Study Start Date :||April 2009|
|Actual Primary Completion Date :||April 2009|
|Actual Study Completion Date :||April 2009|
- Primary objectives of the study are to enable analysis of patient outcomes 2 years following final treatment and estimate the effectiveness of the device in eradicating, decreasing and downgrading of the diseases. [ Time Frame: 2 years post-treatment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00785239
|Principal Investigator:||William Krimsky, M.D.||Franklin Square Hospital Center|